992 Shares in Axon Enterprise, Inc $AXON Acquired by Guidance Capital Inc.

Guidance Capital Inc. purchased a new position in Axon Enterprise, Inc (NASDAQ:AXON) in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 992 shares of the biotechnology company’s stock, valued at approximately $537,000.

A number of other institutional investors have also added to or reduced their stakes in the stock. Vanguard Group Inc. lifted its holdings in shares of Axon Enterprise by 0.6% in the fourth quarter. Vanguard Group Inc. now owns 9,367,224 shares of the biotechnology company’s stock worth $5,319,928,000 after buying an additional 53,060 shares in the last quarter. Geode Capital Management LLC boosted its position in shares of Axon Enterprise by 1.6% during the fourth quarter. Geode Capital Management LLC now owns 2,226,159 shares of the biotechnology company’s stock worth $1,265,657,000 after acquiring an additional 35,544 shares during the last quarter. Sands Capital Management LLC grew its stake in Axon Enterprise by 11.6% during the fourth quarter. Sands Capital Management LLC now owns 1,609,436 shares of the biotechnology company’s stock valued at $914,047,000 after acquiring an additional 167,095 shares in the last quarter. Wellington Management Group LLP grew its stake in Axon Enterprise by 326.9% during the fourth quarter. Wellington Management Group LLP now owns 1,539,738 shares of the biotechnology company’s stock valued at $874,463,000 after acquiring an additional 1,179,038 shares in the last quarter. Finally, Edgewood Management LLC bought a new stake in Axon Enterprise in the 4th quarter valued at $846,516,000. 79.08% of the stock is owned by hedge funds and other institutional investors.

Axon Enterprise News Roundup

Here are the key news stories impacting Axon Enterprise this week:

• Positive Sentiment: Connected Devices remain a key growth engine: Strong demand for TASER devices, body cameras and counter-drone equipment is driving rapid growth in Axon’s hardware and connected-products business. This supports the company’s broader ecosystem of cloud software and public-safety services. Will Strength in Connected Devices Unit Continue to Drive AXON’s Growth?
• Positive Sentiment: Recent earnings and AI capabilities support the bullish case: Axon exceeded quarterly expectations with adjusted EPS of $1.88 versus $1.84 expected and revenue of approximately $904.4 million versus $876.4 million expected. Revenue increased 35.3% year over year, while new AI capabilities could improve the value of Axon’s public-safety platform. Axon Public Safety and New AI Capabilities
• Neutral Sentiment: Technical consolidation follows a sharp advance: AXON had been in a strong uptrend and is now consolidating, leaving investors focused on whether the rally can resume or whether the shares need to reset after their recent gains. Is the Axon Rally Over?
• Negative Sentiment: Valuation is the main pressure point: Analysts note that Axon’s strong growth is already reflected in the stock price. With a very high price-to-earnings ratio, even solid results may not be enough to sustain upward momentum, prompting some investors to downgrade the shares or take profits. Axon Q2 Was Strong but Valuation Concerns Remain
• Negative Sentiment: Insider selling adds a modest sentiment headwind: CEO Patrick Smith sold 9,930 shares for approximately $5.45 million under a pre-arranged Rule 10b5-1 plan. The sale represented only about 0.33% of his holdings, so it is not a major change in insider ownership but may reinforce profit-taking concerns.

Wall Street Analyst Weigh In

Several brokerages have commented on AXON. UBS Group boosted their price target on shares of Axon Enterprise from $440.00 to $600.00 and gave the stock a “neutral” rating in a research note on Thursday, August 6th. Royal Bank Of Canada reaffirmed an “outperform” rating on shares of Axon Enterprise in a report on Tuesday, July 21st. Weiss Ratings reiterated a “hold (c-)” rating on shares of Axon Enterprise in a research report on Wednesday, August 5th. JPMorgan Chase & Co. increased their target price on Axon Enterprise from $750.00 to $755.00 and gave the company an “overweight” rating in a research report on Thursday, May 7th. Finally, Morgan Stanley boosted their price target on shares of Axon Enterprise from $600.00 to $640.00 and gave the stock an “overweight” rating in a research report on Thursday, August 6th. Thirteen analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. Based on data from MarketBeat.com, Axon Enterprise has a consensus rating of “Moderate Buy” and a consensus target price of $730.92.

Axon Enterprise Stock Down 5.7%

Shares of NASDAQ:AXON opened at $599.78 on Thursday. The company has a market cap of $48.73 billion, a price-to-earnings ratio of 248.87, a PEG ratio of 12.98 and a beta of 1.39. Axon Enterprise, Inc has a 12 month low of $339.01 and a 12 month high of $794.29. The company has a current ratio of 2.15, a quick ratio of 1.80 and a debt-to-equity ratio of 0.47. The company has a 50-day moving average price of $521.48 and a 200 day moving average price of $473.41.

Axon Enterprise (NASDAQ:AXON) last issued its quarterly earnings data on Tuesday, August 4th. The biotechnology company reported $1.88 earnings per share for the quarter, topping the consensus estimate of $1.84 by $0.04. Axon Enterprise had a return on equity of 2.84% and a net margin of 6.19%.The company had revenue of $904.39 million for the quarter, compared to analysts’ expectations of $876.42 million. During the same period in the previous year, the firm posted $2.12 earnings per share. The firm’s revenue for the quarter was up 35.3% on a year-over-year basis. As a group, equities research analysts predict that Axon Enterprise, Inc will post 1.63 earnings per share for the current year.

Insider Transactions at Axon Enterprise

In other news, CRO Cameron Brooks sold 1,242 shares of the business’s stock in a transaction that occurred on Thursday, June 4th. The stock was sold at an average price of $500.00, for a total transaction of $621,000.00. Following the transaction, the executive owned 49,710 shares of the company’s stock, valued at approximately $24,855,000. The trade was a 2.44% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Elizabeth Reid Coughlin sold 1,554 shares of the stock in a transaction on Thursday, June 4th. The shares were sold at an average price of $485.00, for a total value of $753,690.00. Following the sale, the insider owned 34,024 shares in the company, valued at $16,501,640. The trade was a 4.37% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last quarter, insiders have sold 68,989 shares of company stock worth $36,016,932. 4.20% of the stock is currently owned by corporate insiders.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.